68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.

Clinical trial NCT06608160 · RECRUITING

Trial details

NCT number: NCT06608160
Sponsor: Ruijin Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

PET / CT Lung Carcinoma Immunotherapy

Start date: 2024-06-20
Primary completion: 2025-08-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.